4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-26-000012
Chief Financial Officer sold 24,002 shares at $1.28 ($30,723)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont Chief Financial Officer | 2026-01-20 | Sale 10b5-1 | −24,002 | $1.28 | $30,723 | 297,214 | D: show line 1 in the form |
| Open-market sales · 24,002 sh · avg $1.28 · $30,723 | |||||||
Loading xslF345X05/wk-form4_1769136395.xml…